|
|
|
|
Rapid- and slow-acting insulins help control diabetes
If the united states' healthcare trend continues on its current course, in 20 years the number of people with diabetes will more than double to 50 million. This dismaying prediction comes from a new report from the Yale Schools of Public Health and Medicine in conjunction with the Institute for Alternative Futures. If the current trend continues, by 2025.
|
| |
More>>
|
|
|
|
|
|
Long-term solutions could lead to lower net drug costs for your benefit plan
As healthcare costs for employers continue to rise, increasing copayments, establishing deductible limits and moving to multi-tier formularies have become common solutions. It is understandable why employers choose these routes because they are simple to deploy, are predictable and highly measurable. However, these strategies don't guarantee a lower total net drug spend.
|
| |
More>>
|
|
|
|
|
|
Prior authorization process lightened by electronic information
Prior authorization is one of those tools that makes physicians and patients frustrated with managed care. Its objectives still remain to manage the utilization of drugs that are: at risk for inappropriate utilization and in some cases toxicity, if used inappropriately; used in ways that fall outside the FDA-approved indication; and high cost. The process, however, has become more streamlined and like most everything else in the 21st century, can be administered electronically, creating less intrusion into the management of the pharmacy benefit.
|
| |
More>>
|
|
|
|
|
|
Unraveling Medicare: A look at Medicare Advantage plans
As Medicare Part D gets under way, attention has largely focused on the prescription drug benefits offered through stand-alone prescription drug plans, or PDPs. Medicare Advantage prescription drug plans (MA-PDPs) are an alternative that could provide seniors an opportunity to save on premiums and co-pays for hospital and doctor fees in addition to gaining a prescription drug benefit.
|
| |
More>>
|
|
|